Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome: the interconnections of epigenetic machinery disorders

Gloria Negri, Pamela Magini, Donatella Milani, Milena Crippa, Elisa Biamino, Maria Piccione, Stefano Sotgiu, Chiara Perrìa, Giuseppina Vitiello, Marina Frontali, Antonella Boni, Elisabetta Di Fede, Maria Chiara Gandini, Elisa Adele Colombo, Michael J. Bamshad, Deborah A. Nickerson, Joshua D. Smith, Italia Loddo, Palma Finelli, Marco SeriTommaso Pippucci, Lidia Larizza, Cristina Gervasini

Research output: Contribution to journalArticle

Abstract

Rubinstein–Taybi syndrome (RSTS) is an autosomal-dominant neurodevelopmental disease affecting 1:125,000 newborns characterized by intellectual disability, growth retardation, facial dysmorphisms and skeletal abnormalities. RSTS is caused by mutations in genes encoding for writers of the epigenetic machinery: CREBBP (~ 60%) or its homologous EP300 (~ 10%). No causative mutation is identified in up to 30% of patients. We performed whole-exome sequencing (WES) on eight RSTS-like individuals who had normal high-resolution array CGH testing and were CREBBP- and EP300-mutation -negative, to identify the molecular cause. In four cases, we identified putatively causal variants in three genes (ASXL1, KMT2D and KMT2A) encoding members of the epigenetic machinery known to be associated with the Bohring–Opitz, Kabuki and Wiedemann–Steiner syndromes. Each variant is novel, de novo, fulfills the ACMG criteria and is predicted to result in loss-of-function leading to haploinsufficiency of the epi-gene. In two of the remaining cases, homozygous/compound heterozygous variants in XYLT2 and PLCB4 genes, respectively, associated with spondyloocular and auriculocondylar 2 syndromes and in the latter an additional candidate variant in XRN2, a gene yet unrelated to any disease, were detected, but their pathogenicity remains uncertain. These results underscore the broad clinical spectrum of Mendelian disorders of the epigenetic apparatus and the high rate of WES disclosure of the genetic basis in cases which may pose a challenge for phenotype encompassing distinct syndromes. The overlapping features of distinct intellectual disability syndromes reflect common pathogenic molecular mechanisms affecting the complex regulation of balance between open and closed chromatin.

Original languageEnglish
Pages (from-to)257-269
Number of pages13
JournalHuman Genetics
Volume138
Issue number3
DOIs
Publication statusPublished - Mar 4 2019

Fingerprint

Exome
Epigenomics
Genes
Intellectual Disability
Mutation
Haploinsufficiency
Disclosure
Chromatin
Virulence
Newborn Infant
Phenotype
Growth

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome : the interconnections of epigenetic machinery disorders. / Negri, Gloria; Magini, Pamela; Milani, Donatella; Crippa, Milena; Biamino, Elisa; Piccione, Maria; Sotgiu, Stefano; Perrìa, Chiara; Vitiello, Giuseppina; Frontali, Marina; Boni, Antonella; Di Fede, Elisabetta; Gandini, Maria Chiara; Colombo, Elisa Adele; Bamshad, Michael J.; Nickerson, Deborah A.; Smith, Joshua D.; Loddo, Italia; Finelli, Palma; Seri, Marco; Pippucci, Tommaso; Larizza, Lidia; Gervasini, Cristina.

In: Human Genetics, Vol. 138, No. 3, 04.03.2019, p. 257-269.

Research output: Contribution to journalArticle

Negri, G, Magini, P, Milani, D, Crippa, M, Biamino, E, Piccione, M, Sotgiu, S, Perrìa, C, Vitiello, G, Frontali, M, Boni, A, Di Fede, E, Gandini, MC, Colombo, EA, Bamshad, MJ, Nickerson, DA, Smith, JD, Loddo, I, Finelli, P, Seri, M, Pippucci, T, Larizza, L & Gervasini, C 2019, 'Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome: the interconnections of epigenetic machinery disorders', Human Genetics, vol. 138, no. 3, pp. 257-269. https://doi.org/10.1007/s00439-019-01985-y
Negri, Gloria ; Magini, Pamela ; Milani, Donatella ; Crippa, Milena ; Biamino, Elisa ; Piccione, Maria ; Sotgiu, Stefano ; Perrìa, Chiara ; Vitiello, Giuseppina ; Frontali, Marina ; Boni, Antonella ; Di Fede, Elisabetta ; Gandini, Maria Chiara ; Colombo, Elisa Adele ; Bamshad, Michael J. ; Nickerson, Deborah A. ; Smith, Joshua D. ; Loddo, Italia ; Finelli, Palma ; Seri, Marco ; Pippucci, Tommaso ; Larizza, Lidia ; Gervasini, Cristina. / Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome : the interconnections of epigenetic machinery disorders. In: Human Genetics. 2019 ; Vol. 138, No. 3. pp. 257-269.
@article{649bd51519b946a0928af9add872e26b,
title = "Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome: the interconnections of epigenetic machinery disorders",
abstract = "Rubinstein–Taybi syndrome (RSTS) is an autosomal-dominant neurodevelopmental disease affecting 1:125,000 newborns characterized by intellectual disability, growth retardation, facial dysmorphisms and skeletal abnormalities. RSTS is caused by mutations in genes encoding for writers of the epigenetic machinery: CREBBP (~ 60{\%}) or its homologous EP300 (~ 10{\%}). No causative mutation is identified in up to 30{\%} of patients. We performed whole-exome sequencing (WES) on eight RSTS-like individuals who had normal high-resolution array CGH testing and were CREBBP- and EP300-mutation -negative, to identify the molecular cause. In four cases, we identified putatively causal variants in three genes (ASXL1, KMT2D and KMT2A) encoding members of the epigenetic machinery known to be associated with the Bohring–Opitz, Kabuki and Wiedemann–Steiner syndromes. Each variant is novel, de novo, fulfills the ACMG criteria and is predicted to result in loss-of-function leading to haploinsufficiency of the epi-gene. In two of the remaining cases, homozygous/compound heterozygous variants in XYLT2 and PLCB4 genes, respectively, associated with spondyloocular and auriculocondylar 2 syndromes and in the latter an additional candidate variant in XRN2, a gene yet unrelated to any disease, were detected, but their pathogenicity remains uncertain. These results underscore the broad clinical spectrum of Mendelian disorders of the epigenetic apparatus and the high rate of WES disclosure of the genetic basis in cases which may pose a challenge for phenotype encompassing distinct syndromes. The overlapping features of distinct intellectual disability syndromes reflect common pathogenic molecular mechanisms affecting the complex regulation of balance between open and closed chromatin.",
author = "Gloria Negri and Pamela Magini and Donatella Milani and Milena Crippa and Elisa Biamino and Maria Piccione and Stefano Sotgiu and Chiara Perr{\`i}a and Giuseppina Vitiello and Marina Frontali and Antonella Boni and {Di Fede}, Elisabetta and Gandini, {Maria Chiara} and Colombo, {Elisa Adele} and Bamshad, {Michael J.} and Nickerson, {Deborah A.} and Smith, {Joshua D.} and Italia Loddo and Palma Finelli and Marco Seri and Tommaso Pippucci and Lidia Larizza and Cristina Gervasini",
year = "2019",
month = "3",
day = "4",
doi = "10.1007/s00439-019-01985-y",
language = "English",
volume = "138",
pages = "257--269",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome

T2 - the interconnections of epigenetic machinery disorders

AU - Negri, Gloria

AU - Magini, Pamela

AU - Milani, Donatella

AU - Crippa, Milena

AU - Biamino, Elisa

AU - Piccione, Maria

AU - Sotgiu, Stefano

AU - Perrìa, Chiara

AU - Vitiello, Giuseppina

AU - Frontali, Marina

AU - Boni, Antonella

AU - Di Fede, Elisabetta

AU - Gandini, Maria Chiara

AU - Colombo, Elisa Adele

AU - Bamshad, Michael J.

AU - Nickerson, Deborah A.

AU - Smith, Joshua D.

AU - Loddo, Italia

AU - Finelli, Palma

AU - Seri, Marco

AU - Pippucci, Tommaso

AU - Larizza, Lidia

AU - Gervasini, Cristina

PY - 2019/3/4

Y1 - 2019/3/4

N2 - Rubinstein–Taybi syndrome (RSTS) is an autosomal-dominant neurodevelopmental disease affecting 1:125,000 newborns characterized by intellectual disability, growth retardation, facial dysmorphisms and skeletal abnormalities. RSTS is caused by mutations in genes encoding for writers of the epigenetic machinery: CREBBP (~ 60%) or its homologous EP300 (~ 10%). No causative mutation is identified in up to 30% of patients. We performed whole-exome sequencing (WES) on eight RSTS-like individuals who had normal high-resolution array CGH testing and were CREBBP- and EP300-mutation -negative, to identify the molecular cause. In four cases, we identified putatively causal variants in three genes (ASXL1, KMT2D and KMT2A) encoding members of the epigenetic machinery known to be associated with the Bohring–Opitz, Kabuki and Wiedemann–Steiner syndromes. Each variant is novel, de novo, fulfills the ACMG criteria and is predicted to result in loss-of-function leading to haploinsufficiency of the epi-gene. In two of the remaining cases, homozygous/compound heterozygous variants in XYLT2 and PLCB4 genes, respectively, associated with spondyloocular and auriculocondylar 2 syndromes and in the latter an additional candidate variant in XRN2, a gene yet unrelated to any disease, were detected, but their pathogenicity remains uncertain. These results underscore the broad clinical spectrum of Mendelian disorders of the epigenetic apparatus and the high rate of WES disclosure of the genetic basis in cases which may pose a challenge for phenotype encompassing distinct syndromes. The overlapping features of distinct intellectual disability syndromes reflect common pathogenic molecular mechanisms affecting the complex regulation of balance between open and closed chromatin.

AB - Rubinstein–Taybi syndrome (RSTS) is an autosomal-dominant neurodevelopmental disease affecting 1:125,000 newborns characterized by intellectual disability, growth retardation, facial dysmorphisms and skeletal abnormalities. RSTS is caused by mutations in genes encoding for writers of the epigenetic machinery: CREBBP (~ 60%) or its homologous EP300 (~ 10%). No causative mutation is identified in up to 30% of patients. We performed whole-exome sequencing (WES) on eight RSTS-like individuals who had normal high-resolution array CGH testing and were CREBBP- and EP300-mutation -negative, to identify the molecular cause. In four cases, we identified putatively causal variants in three genes (ASXL1, KMT2D and KMT2A) encoding members of the epigenetic machinery known to be associated with the Bohring–Opitz, Kabuki and Wiedemann–Steiner syndromes. Each variant is novel, de novo, fulfills the ACMG criteria and is predicted to result in loss-of-function leading to haploinsufficiency of the epi-gene. In two of the remaining cases, homozygous/compound heterozygous variants in XYLT2 and PLCB4 genes, respectively, associated with spondyloocular and auriculocondylar 2 syndromes and in the latter an additional candidate variant in XRN2, a gene yet unrelated to any disease, were detected, but their pathogenicity remains uncertain. These results underscore the broad clinical spectrum of Mendelian disorders of the epigenetic apparatus and the high rate of WES disclosure of the genetic basis in cases which may pose a challenge for phenotype encompassing distinct syndromes. The overlapping features of distinct intellectual disability syndromes reflect common pathogenic molecular mechanisms affecting the complex regulation of balance between open and closed chromatin.

UR - http://www.scopus.com/inward/record.url?scp=85062358315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062358315&partnerID=8YFLogxK

U2 - 10.1007/s00439-019-01985-y

DO - 10.1007/s00439-019-01985-y

M3 - Article

C2 - 30806792

AN - SCOPUS:85062358315

VL - 138

SP - 257

EP - 269

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 3

ER -